Press Releases

17 Sep '20
Acutus Medical Reports Second Quarter 2020 Financial Results
CARLSBAD, Calif., Sept. 17, 2020 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), today reported financial results for its second quarter ended June 30, 2020. Recent Highlights: Reported revenue of $1.1 million in the second quarter of 2020, a 54% increase over the same quarter
03 Sep '20
Acutus Medical to Announce Second Quarter 2020 Financial Results
CARLSBAD, Calif., Sept. 03, 2020 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), today announced it will release its financial results for the second quarter of 2020 after market close on Thursday, September 17, 2020. In conjunction with the release, Acutus will host a
05 Aug '20
Acutus Medical Announces Pricing of Initial Public Offering
CARLSBAD, Calif., Aug. 05, 2020 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus”) (NASDAQ: AFIB) today announced the pricing of its initial public offering of 8,823,529 shares of its common stock at a price to the public of $18.00 per share. All of the shares are being offered by Acutus.
20 May '20
New Alliance Maps the Way in Electrophysiology
A New Strategic Alliance Between BIOTRONIK, A Leader In Cardiac Rhythm Management, and Acutus Medical, Electrophysiology Innovator, Expected to Offer More Efficient and Effective Diagnosis and Treatment for Arrhythmia Patients CARLSBAD, California, and BERLIN, Germany, May 20, 2020 – Acutus Medical
Displaying 51 - 60 of 93